Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PUR Biologics
Irvine, California, United Statesfacebook.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
PUR Biologics has launched PURbonedough™, a next-generation bone graft substitute for spinal fusion derived from human tissue. The company also markets advanced allografts, demineralized extracellular matrixes, synthetic solutions, and cellular-derived tissues. Future products are in development for stem cell and growth factor-driven therapeutics targeting osteoarthritis and cartilage regeneration. The company is actively shipping products to distributors with strong market feedback[6].
- Therapeutic areas
- OtherRheumatology
- Modalities
- Allograft (Biologic)Demineralized extracellular matrix (Biologic)Synthetic solution (Device/Biologic hybrid)Cellular derived tissue (Cell therapy/biologic)Stem cell therapy (future pipeline)Growth factor therapy (future pipeline)
- Industry
- Implantable Medical Devices
02
Partnerships
Extensive network of direct sales and strategic sales partners (~300 representatives nationwide)
Beyond the preview
Go deeper on PUR Biologics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PUR Biologics.